P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)

スポンサーリンク

概要

著者

関連論文

Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
Complete parallelism between enhancement of dopamine β -hydroxylase activity and increase in the rate of cell proliferation in adrenal medulla of male rats after reserpine treatment.
Progesterone and medroxyprogesterone acetate accelerate the chronic nephropathy in female F344 rats
EXAMINATION OF PERCUTANEOUS APPLICATION IN A 26-WEEK CARCINOGENICITY TEST IN CB6F1-TG rasH2 MICE
Induction of Drug Metabolism-Related Enzymes by Methylcholanthrene and Phenobarbital in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene and Their Wild Type Littermates
Use of IC tags in short-term carcinogenicity studies on CB6F1-TgrasH2 mice(Carcinogenicity, Proceedings of the 32nd Annual Meeting)
P8-31 Effect of vehicles for a dermal carcinogenicity testing of CB6F1-TgrasH2 mice(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
P6-41 Comparative study on the carcinogenicity of phenolphthalein in rasH2 and p53 knockout mice(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
Influence of the administration route and the vehicle on CB6F1-TgrasH2 mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Background data of human prototype c-Ha-ras transgenic (CB6Fl-TgrasH2) mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Biological characteristics of gene-manipulated mice for carcinogenicity test (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
USE OF IC TAGS IN SHORT-TERM CARCINOGENICITY STUDY ON CB6F1 TGrasH2 MICE
Effects of in utero propylthiouracil exposure on the monoamine content of the rat fetus brain(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
Effects of the p38 MAP kinase inhibitor SB203580 on the immune system of rats(Immune system, Allergy, Proceedings of the 32nd Annual Meeting)
Tissue distribution of rat plasma released enzymes(Blood, Proceedings of the 32nd Annual Meeting)
P-66 Effects of Tamoxlfen Treatment on the Uterus and Ovary In Rats.(Proceedings of the 27th Annual Meeting)
P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)
P7-06 Time-course changes in morphology of the spleen and antibody production in rats after sheep red blood cells(SRBC)-immunization(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTAT
Comparison of single doses of vincristine (VCR), cyclophosphamide (CP) and 5-fluorouracil (5-FU)-induced toxicity development and recovery in rat hemopoietic system (IMMUNE AND ALLERGIC SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the
Report 1 : TESTING FOR CARCINOGENICITY OF PHARMACEUTICALS : S1, A ; Conditions which require carcinogenicity studies for pharmaceuticals S1, B ; Use of two rodent species S1, C ; Dose selection for carcinogenicity studies of pharmaceuticals (CA
Carcinogenic comparative study on rasH2 mice produced by two breeding facilities

もっと見る

スポンサーリンク